- Exchange: -
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Axiogenesis AG
AI8:GR
Ticker Delisted
Snapshot for Axiogenesis AG (AI8)
| Open: | - | Day's Range: | - | Volume: | 0 | Bid: | - |
|---|---|---|---|---|---|---|---|
| Previous Close: | - | 52wk Range: | - | 1-Yr Rtn: | - | Ask: | - |
Key Statistics for AI8
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (-) | - |
| Earnings Per Share () (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.15 |
| Enterprise Value (M EUR) (ttm) | - |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | - |
More AI8 Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for AI8
No data available.
Company Profile & Key Executives for AI8
Axiogenesis AG is a biotechnology company. The Company develops novel assays that use differentiated embryonic stem cell that display normal physiological behavior. Axiogenesis products are used in pharmacology and safety screening in the pharmaceutical, chemical, and cosmetics industries.
| Heribert BohlenCEO/Member:Executive Board | Bernd FronholffCFO/COO/Member:Executive Board |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page